Last reviewed · How we verify
NCT04918199: iBox vs Human
Human Versus Computer-based Predictions of Long Allograft Survival
trial testing Computer based assessment (iBox) in Kidney Transplant Failure in 400 participants. Completed in 31 December 2021.
31 December 2021
Quick facts
| Lead sponsor | Paris Translational Research Center for Organ Transplantation |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 1 March 2018 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across France |
Drugs / interventions tested
- Computer based assessment (iBox)
- Physician assessement
Conditions studied
- Kidney Transplant Failure — all drugs for Kidney Transplant Failure →
Sponsor
Paris Translational Research Center for Organ Transplantation — full company profile →
Who can join
18 and older, any sex, with Kidney Transplant Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The clinical decision-making after kidney transplantation is mainly driven by patient individual assessment. However, this task remains difficult and uncertain due to the integration of complex and numerous parameters. We aim to evaluate and compare the ability of transplant physicians to predict long term allograft survival compared with a computer-based survival prediction algorithm (iBox system).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of artificial intelligence and human-based prediction and stratification of the risk of long-term kidney allograft failure.
Divard G, Raynaud M, Tatapudi VS, Abdalla B, et al · · 2022 · cited 21× · PMID 36418380 · DOI 10.1038/s43856-022-00201-9
Verify or expand the search:
- PubMed search for NCT04918199
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Transplant Failure
Currently open trials in the same condition.
- NCT06186843 — Plant-based Diet for Kidney Transplant Recipients · NA · active not recruiting
- NCT05897047 — The smartNTx Trial: A Prospective, Randomized Controlled Trial (RCT) to Investigate Additional Interventional Telemedica · NA · active not recruiting
- NCT06505200 — Observational Cohort Study Renal Transplantation University Hospitals Leuven · active not recruiting
Other Paris Translational Research Center for Organ Transplantation trials
Trials by the same sponsor.
- NCT07532382 — Personalized Stories for Pediatric Kidney Recipients · recruiting
- NCT07091214 — Molecular Transcriptomics in Diagnosing Pediatric Kidney Transplant Rejection: the PANDA-Kids-ATLAS Study · not yet recruiting
- NCT07269275 — HLA Eplet Mismatches to Predict Long-term Kidney Transplant Outcomes · completed
- NCT06496269 — Impact of Microvascular Inflammation on Kidney Allograft Outcome · completed
- NCT06436586 — Impact of HLA Evolutionary Divergence and HLA Donor-recipient Molecular Mismatches on Kidney Allograft Rejection · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04918199 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Paris Translational Research Center for Organ Transplantation
- Last refreshed: 28 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04918199.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing